Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | INFLUX Influx Healthtech Ltd. Pharma · SME | VILINBIO VILIN BIO MED LTD. Pharma · SME | GML Galaxy Medicare Ltd. Pharma · SME | POLYMED Poly Medicure Limited Pharma · Large |
|---|---|---|---|---|
| Final Score | 16 | 35 | 65 | 35 |
| Verdict | OVERVALUED | WATCHLIST | UNDERVALUED | WATCHLIST |
| Style | OVERVALUED | WATCHLIST | Deep Value | WATCHLIST |
| Piotroski | 5/9 | 7/9 | 8/9 | 8/9 |
| Valuation | 2/30 | 4/30 | 30/30 | 1/30 |
| Growth | 3/25 | 20/25 | 19/25 | 14/25 |
| Quality | 0/20 | 1/20 | 0/20 | 0/20 |
| Balance Sheet | 7/15 | 11/15 | 14/15 | 10/15 |
| Cash Flow | 1/10 | 2/10 | 4/10 | 4/10 |
| Price | ₹233.05 | ₹48.7 | ₹18.3 | ₹1,458.8 |
| P/E | 26.20 | 38.40 | 8.54 | 42.80 |
| P/B | — | 2.61 | 0.72 | 4.52 |
| ROE | — | 7.51% | 10.60% | 11.20% |
| ROCE | — | 10.80% | 13.60% | 14.00% |
| Debt / Equity | 0.00 | 0.01 | 0.10 | 0.11 |
| FCF Yield | — | 0.54% | — | 0.15% |
| Dividend Y | — | — | 1.82% | 0.25% |
| Altman Z | 0.00 | 8.33 | 4.20 | 8.23 |
| Promoter % | 73.53% | 56.65% | 72.98% | 62.42% |
| Mkt Cap (₹Cr) | 539.00 | 74.20 | 29.20 | 14016.00 |
| Graham # | — | ₹23.05 | ₹36.7 | ₹467.77 |
| Fair PE | 7.9 | 42.0 | 42.0 | 42.0 |
| MoS % | -230.9% | +8.7% | +80.6% | -9.3% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startINFLUX173
VILINBIO217
GML39
POLYMED52